临床医药文献电子杂志
臨床醫藥文獻電子雜誌
림상의약문헌전자잡지
Journal of Clinical Medical Literature (ElectronicEdition)
2015年
9期
1667-1668
,共2页
奥曲肽联合普萘洛尔%肝硬化上消化道出血%临床疗效%观察
奧麯肽聯閤普萘洛爾%肝硬化上消化道齣血%臨床療效%觀察
오곡태연합보내락이%간경화상소화도출혈%림상료효%관찰
目的:探讨奥曲肽联合普萘洛尔在对肝硬化上消化道出血患者在治疗过程中的疗效。方法收集80例肝硬化上消化道出血患者,随机分为观察组和对照组,各40例。结果两组患者在经过治疗后均有所好转,但观察组患者的治疗总有效率(98%)明显优于对照组患者的治疗总有效率(80%),同时观察组患者的并发症发生率(4%)明显优于对照组患者的并发症发生率(12%)。所有差异均有统计学意义(P<0.05)。结论在李村女皇治疗肝硬化上消化道出血患者的过程中,通过使用奥曲肽联合普萘洛尔进行治疗的方法疗效更佳,并发症发生率更低,在临床上值得推广应用。
目的:探討奧麯肽聯閤普萘洛爾在對肝硬化上消化道齣血患者在治療過程中的療效。方法收集80例肝硬化上消化道齣血患者,隨機分為觀察組和對照組,各40例。結果兩組患者在經過治療後均有所好轉,但觀察組患者的治療總有效率(98%)明顯優于對照組患者的治療總有效率(80%),同時觀察組患者的併髮癥髮生率(4%)明顯優于對照組患者的併髮癥髮生率(12%)。所有差異均有統計學意義(P<0.05)。結論在李村女皇治療肝硬化上消化道齣血患者的過程中,通過使用奧麯肽聯閤普萘洛爾進行治療的方法療效更佳,併髮癥髮生率更低,在臨床上值得推廣應用。
목적:탐토오곡태연합보내락이재대간경화상소화도출혈환자재치료과정중적료효。방법수집80례간경화상소화도출혈환자,수궤분위관찰조화대조조,각40례。결과량조환자재경과치료후균유소호전,단관찰조환자적치료총유효솔(98%)명현우우대조조환자적치료총유효솔(80%),동시관찰조환자적병발증발생솔(4%)명현우우대조조환자적병발증발생솔(12%)。소유차이균유통계학의의(P<0.05)。결론재리촌녀황치료간경화상소화도출혈환자적과정중,통과사용오곡태연합보내락이진행치료적방법료효경가,병발증발생솔경저,재림상상치득추엄응용。
Objective To investigate the octreotide combined propranolol in patients with liver cirrhosis upper gastrointestinal bleeding in curative effect of the treatment process. Methods Collect 80 patients with liver cirrhosis upper gastrointestinal bleeding, randomly divided into observation group and control group, 40 cases each. Results After treatment in both groups were improved, but the treatment of patients with observation group total effective rate 98%is better than control group in the treatment of patients with total effective rate 80%, at the same time, the complication rate of observation group of patients with 4% better than the control group patients complication rate was 12%. All the differences were statistical signiifcance (P<0.05). Conclusion In litsun queen in the process of the treatment of patients with liver cirrhosis upper gastrointestinal bleeding, by using the octreotide combined propranolol treatment method of the curative effect is much better, lower incidence of complications, worthy of popularization and application in clinic.